Lauren McDonough
Physician Assistant · Burlington, NCNPI 1013587674
Payments from drug & device makers
Across 159 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$311
- Novo Nordisk$294
- Lilly USA, LLC$292
- AstraZeneca$260
- AbbVie$229
- Jazz Pharmaceuticals Inc.$147
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,81198%
- Education$672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 19 | $311 |
| Novo Nordisk | 22 | $294 |
| Lilly USA, LLC | 18 | $292 |
| AstraZeneca | 14 | $260 |
| AbbVie | 12 | $229 |
| Jazz Pharmaceuticals Inc. | 5 | $147 |
| Mylan Specialty L.p. | 5 | $136 |
| Axsome Therapeutics, Inc. | 7 | $134 |
| Insmed, Inc. | 5 | $100 |
| Merck | 4 | $73 |
| Exact Sciences | 4 | $67 |
| GSK | 4 | $66 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 3 | $58 |
| Neurocrine Biosciences, Inc. | 2 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Corcept Therapeutics | 2 | $50 |
| Dexcom, Inc. | 2 | $38 |
| Insulet Corporation | 1 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Viatris Specialty LLC | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Philips North America LLC | 1 | $25 |
| Harmony Biosciences LLC | 1 | $25 |
| Organogenesis Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Mannkind Corporation | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Bayer | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Medtronic | 1 | $16 |
| Exeltis, USA Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Novartis | 1 | $15 |
| Abbott | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
How this compares
$2,878 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $50,930 |
| TrulicityDulaglutide | 30 | $42,982 |
| RybelsusSemaglutide | 40 | $37,284 |
| MounjaroTirzepatide | 30 | $30,391 |
| JardianceEmpagliflozin | 27 | $29,192 |
| OzempicSemaglutide | 17 | $27,266 |
| EliquisApixaban | 30 | $17,116 |
| FarxigaDapagliflozin Propanediol | 28 | $16,838 |
| JanuviaSitagliptin Phosphate | 18 | $15,176 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $11,825 |
| Spiriva HandihalerTiotropium Bromide | 11 | $8,932 |
| LinzessLinaclotide | 11 | $6,539 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,830 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,681 |
| Omeprazole | 105 | $1,441 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $292 | $73,37460 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $66 | $66,584108 claims |
| Novo NordiskRybelsus, Ozempic | $294 | $64,55057 claims |
| Boehringer IngelheimJardiance | $16 | $29,19227 claims |
| PfizerEliquis | $311 | $17,11630 claims |
| AstraZenecaFarxiga | $260 | $16,83828 claims |
| MerckJanuvia | $73 | $15,17618 claims |
| AbbVieLinzess | $229 | $6,53911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Burlington
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.